Published

SERI and Carl Zeiss Meditec collaborate to improve vision care in Singapore

Summary by Med-Tech Innovation | Latest News for the Medical Device Industry
The Singapore Eye Research Institute (SERI) and Carl Zeiss Meditec AG, one of the world's leading medical technology companies, have entered into a strategic partnership to advance surgical outcomes in refractive and cataract surgeries.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)